Literature DB >> 19419275

Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders.

Astrid Pañeda1, Lucia Vanrell, Itsaso Mauleon, Julien S Crettaz, Pedro Berraondo, Eric J Timmermans, Stuart G Beattie, Jaap Twisk, Sander van Deventer, Jesus Prieto, Antonio Fontanellas, Maria Sol Rodriguez-Pena, Gloria Gonzalez-Aseguinolaza.   

Abstract

Recombinant adeno-associated viral (AAV) vectors have unique properties, which make them suitable vectors for gene transfer. Here we assess the liver transduction efficiency and biodistribution of AAV-pseudotyped capsids (serotypes) 1, 5, 6, and 8, combined with single-stranded and double-stranded genomic AAV2 structures carrying the luciferase reporter gene after systemic administration. The analysis was performed in vivo and ex vivo, in male and female mice. Gender-related differences in AAV-mediated transduction and biodistribution were shown for the four serotypes. Our data confirm the superiority of AAV8 over the rest of the serotypes, as well as a significant advantage of double-stranded genomes in terms of liver transduction efficiency, particularly in females. Regarding biodistribution, AAV5 displayed a narrower tropism than the other serotypes tested, transducing, almost exclusively, the liver. Interestingly, AAV1 and AAV8, in particular those having single-stranded genomes, showed high transduction efficiency of female gonads. However, no inadvertent germ line transmission of AAV genomes was observed after breeding single-stranded AAV8-injected female mice with untreated males. In conclusion, double-stranded AAV8 vectors led to the highest levels of liver transduction in mice, as demonstrated by luciferase expression. Nevertheless, the transduction of other organs with AAV8 vectors could favor the use of less efficient serotypes, such as AAV5, which display a narrow tropism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19419275     DOI: 10.1089/hum.2009.031

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  48 in total

1.  Sustained enzymatic correction by rAAV-mediated liver gene therapy protects against induced motor neuropathy in acute porphyria mice.

Authors:  Carmen Unzu; Ana Sampedro; Itsaso Mauleón; Manuel Alegre; Stuart G Beattie; Rafael Enríquez de Salamanca; Jolanda Snapper; Jaap Twisk; Harald Petry; Gloria González-Aseguinolaza; Julio Artieda; María Sol Rodríguez-Pena; Jesús Prieto; Antonio Fontanellas
Journal:  Mol Ther       Date:  2010-09-28       Impact factor: 11.454

2.  Mouse gender influences brain transduction by intravascularly administered AAV9.

Authors:  Casey A Maguire; Matheus Hw Crommentuijn; Dakai Mu; Eloise Hudry; Alberto Serrano-Pozo; Bradley T Hyman; Bakhos A Tannous
Journal:  Mol Ther       Date:  2013-08       Impact factor: 11.454

3.  Development of a liver-specific Tet-on inducible system for AAV vectors and its application in the treatment of liver cancer.

Authors:  Lucia Vanrell; Marianna Di Scala; Laura Blanco; Itziar Otano; Irene Gil-Farina; Victor Baldim; Astrid Paneda; Pedro Berraondo; Stuart G Beattie; Abdelwahed Chtarto; Lilianne Tenenbaum; Jesús Prieto; Gloria Gonzalez-Aseguinolaza
Journal:  Mol Ther       Date:  2011-03-01       Impact factor: 11.454

4.  Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5ch and AAV1.

Authors:  Anna Majowicz; David Salas; Nerea Zabaleta; Estefania Rodríguez-Garcia; Gloria González-Aseguinolaza; Harald Petry; Valerie Ferreira
Journal:  Mol Ther       Date:  2017-06-05       Impact factor: 11.454

5.  Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research.

Authors:  Kelsey E Jarrett; Ciaran Lee; Marco De Giorgi; Ayrea Hurley; Baiba K Gillard; Alexandria M Doerfler; Ang Li; Henry J Pownall; Gang Bao; William R Lagor
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

6.  AAV vectors avoid inflammatory signals necessary to render transduced hepatocyte targets for destructive T cells.

Authors:  Suryanarayan Somanathan; Ekaterina Breous; Peter Bell; James M Wilson
Journal:  Mol Ther       Date:  2010-03-16       Impact factor: 11.454

7.  Systemic gene transfer to skeletal muscle using reengineered AAV vectors.

Authors:  Jana L Phillips; Julia Hegge; Jon A Wolff; R Jude Samulski; Aravind Asokan
Journal:  Methods Mol Biol       Date:  2011

8.  Adeno-associated virus mediated delivery of an engineered protein that combines the complement inhibitory properties of CD46, CD55 and CD59.

Authors:  Derek Leaderer; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  J Gene Med       Date:  2015 Jun-Jul       Impact factor: 4.565

9.  Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism.

Authors:  S K Powell; N Khan; C L Parker; R J Samulski; G Matsushima; S J Gray; T J McCown
Journal:  Gene Ther       Date:  2016-09-15       Impact factor: 5.250

10.  Establishment of an AAV reverse infection-based array.

Authors:  Xiaoyan Dong; Wenhong Tian; Gang Wang; Zheyue Dong; Wei Shen; Gang Zheng; Xiaobing Wu; Jinglun Xue; Yue Wang; Jinzhong Chen
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.